Larimar Therapeutics to Present at the William Blair Biotech Focus Conference 2021

Rhea-AI Summary

Larimar Therapeutics (Nasdaq: LRMR) announced that CEO Carole Ben-Maimon will participate in the William Blair Biotech Focus Conference 2021, scheduled virtually for July 14-15. Dr. Ben-Maimon will engage in a fireside chat on July 15 at 3:00 PM ET, discussing the company's development of treatments for complex rare diseases. Larimar's lead candidate, CTI-1601, is being evaluated for Friedreich's ataxia in a Phase 1 program. A replay of the chat will be accessible on Larimar's website.

BALA CYNWYD, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that Carole Ben-Maimon, MD, President and Chief Executive Officer of Larimar Therapeutics, will present and participate in 1x1 investor meetings at the William Blair Biotech Focus Conference 2021 taking place virtually from July 14-15, 2021. See below for more details.

Presentation Format:	Fireside chat
Date:	July 15, 2021
Time:	3:00 PM ET
Webcast Link:	https://wsw.com/webcast/blair59/lrmr/1958264

A replay of the fireside chat will be available on the “Events and Presentations” section of the Larimar website: https://investors.larimartx.com/events-and-presentations/presentations.

About Larimar Therapeutics

Larimar Therapeutics, Inc. (Nasdaq: LRMR) is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. Larimar’s lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program in the U.S. as a potential treatment for Friedreich's ataxia. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. For more information, please visit: https://larimartx.com.

Investor Contact:
Joyce Allaire
LifeSci Advisors
jallaire@lifesciadvisors.com
(212) 915-2569

Company Contact:
Michael Celano
Chief Financial Officer
mcelano@larimartx.com
(484) 414-2715

FAQ

When will Larimar Therapeutics participate in the William Blair Biotech Focus Conference 2021?

Larimar Therapeutics will participate in the William Blair Biotech Focus Conference 2021 on July 14-15, 2021.

What is the date and time of Larimar's CEO presentation at the conference?

The presentation by CEO Carole Ben-Maimon is scheduled for July 15, 2021, at 3:00 PM ET.

Where can I watch the Larimar Therapeutics fireside chat?

The fireside chat can be watched at this link: Fireside Chat Link.

What is the lead candidate of Larimar Therapeutics?

Larimar's lead candidate is CTI-1601, which is being evaluated for Friedreich's ataxia.

How can I access the replay of the presentation by Larimar Therapeutics?

The replay will be available in the 'Events and Presentations' section of Larimar's website.